Literature DB >> 15777842

The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL.

Jian Wang1, Kostas Pantopoulos.   

Abstract

Iron regulatory protein 2 (IRP2), a posttranscriptional regulator of iron metabolism, is subjected to iron-dependent degradation by the proteasome. Recent experiments proposed a mechanism involving 2-oxoglutarate-dependent oxygenases. Enzymes of this class, such as prolyl-4-hydroxylases, mediate the oxygen and iron-dependent degradation of the hypoxia inducible factor HIF-1alpha, which requires the E3 ubiquitin ligase activity of pVHL. Considering that the pathways for IRP2 and HIF-1alpha degradation share remarkable similarities, we investigated whether pVHL may also be involved in the degradation of IRP2. We show here that IRP2 can interact with pVHL in co-transfection/co-immunoprecipitation assays. Furthermore, pVHL is able to promote the ubiquitination and the decay of transfected IRP2. However, the iron-dependent degradation of endogenous IRP2 is not impaired in VHL-deficient cell lines, suggesting that pVHL is not a necessary component of this pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777842     DOI: 10.1016/j.bbamcr.2004.08.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Hypoxia inducible factor prolyl 4-hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress.

Authors:  Ambreena Siddiq; Leila R Aminova; Rajiv R Ratan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

2.  Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties.

Authors:  Orly Weinreb; Tamar Amit; Silvia Mandel; Moussa B H Youdim
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

3.  Human iron regulatory protein 2 is easily cleaved in its specific domain: consequences for the haem binding properties of the protein.

Authors:  Camille Dycke; Catherine Bougault; Jacques Gaillard; Jean-Pierre Andrieu; Kostas Pantopoulos; Jean-Marc Moulis
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

4.  Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2.

Authors:  H J Choi; B-J Song; Y-D Gong; W J Gwak; Y Soh
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

5.  ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma.

Authors:  Yangsook Song Green; Maria C Ferreira Dos Santos; Daniel G Fuja; Ethan C Reichert; Alexandre R Campos; Sophie J Cowman; Karen Acuña Pilarte; Jessica Kohan; Sheryl R Tripp; Elizabeth A Leibold; Deepika Sirohi; Neeraj Agarwal; Xiaohui Liu; Mei Yee Koh
Journal:  Oncogene       Date:  2022-09-12       Impact factor: 8.756

6.  Iron-dependent degradation of IRP2 requires its C-terminal region and IRP structural integrity.

Authors:  Jian Wang; Guohua Chen; Julie Lee; Kostas Pantopoulos
Journal:  BMC Mol Biol       Date:  2008-01-28       Impact factor: 2.946

Review 7.  The human side of hypoxia-inducible factor.

Authors:  Thomas G Smith; Peter A Robbins; Peter J Ratcliffe
Journal:  Br J Haematol       Date:  2008-05       Impact factor: 6.998

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.